PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Change In Chief Financial Officer Of The Company
Pursuant to regulation 30 of the SEBI (LODR) Regulation 2015, we would like to inform you that the Board of Directors of the Company, at its meeting held today, have appointed Ms. Mrinalini Srinivasan as Chief Financial Officer of the Company effective June 29,2024 PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
In accordance with Regulation 30 of the SEBI (LODR) Regulation 2015, we hereby inform you that Mr. Prashant Bhatnagar, Chief Financial Officer has tendered resignation as the Chief Financial Officer of the Company effective close of business hours of June 28,2024 as he will be leaving P&G. The Letter of resignation is enclosed herewith. Further, we would like to inform you that the Board at its meeting held today, have appointed Ms. Mrinalini Srinivasan as Chief Financial Officer of the Company effective June 29,2024. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed details with respect to loss of share certificates of shareholder(s) of the Company PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Intimation Of Change In Telephone & Fax Number Of The Company
Pursuant to regulation 46 of the SEBI (LODR) Regulations 2015, the telephone number and fax number of the Company will be changed as per enclosed letter. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Change In Managing Director Of The Company Letter Of Resignation
Further to our letter dated March 18,2024, enclosed is the copy of the letter of resignation from Mr. L. V. Vaidyanathan.
Procter & Gamble Health Reports 21% Drop In Q3 PAT
Procter & Gamble Health reported a 21% drop in profit after tax to Rs 46 crore for the third quarter ended March 2024, with revenue from operations declining to Rs 252 crore.
Procter & Gamble Hygiene & Healthcare's March quarter profit dips 7%
During the quarter, PGHH's operating revenue grew by 13.4% year-on-year to Rs 1002.2 crore - up from Rs 889.1 crore. The company follows a July to June financial year. Q3FY24 Quarterly Result Announced for Procter & Gamble Hygiene & Healthcare Ltd.
Personal Products company Procter & Gamble Hygiene & Healthcare announced Q3FY24 results: Financial Highlights: - Procter & Gamble Hygiene and Health Care reported sales of Rs 998 crore. - There was a 13% increase in sales YoY. - The Profit After Tax was Rs 154 crore. - PAT saw a 50% operational increase. - Despite the operational rise, reported profit after tax was down by 6% versus the previous year, attributable to one-time tax impacts. LV Vaidyanathan, Managing Director, commented on the performance stating, "We delivered strong top-line growth despite a challenging operating environment, driven by superior products that are delighting and serving consumers' evolving needs. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority across product performance, packaging, brand communication, retail execution and consumer and customer value - productivity, constructive disruption, and an agile and accountable organization. We are confident that these strategies will help us navigate the mid-term and deliver balanced growth and value creation.” Result PDF PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Find enclosed press release on the unaudited financial results for the quarter ended March 31,2024 PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Find enclosed press release on the unaudited financial results for the quarter ended March 31,2024